Jan 30, 2020
Following a successful 2019, Abingdon Health is expanding its York-based facility, giving the company the space and capabilities necessary to continue to drive forward rapid diagnostic testing innovation and growth.
Read More
Nov 25, 2019
Certification of new Cambridge facility smooths path to future IVD approvals
Read More
Nov 18, 2019
International panel of pathologists drive forward-thinking agenda on role of pathology in transforming cancer diagnostics and improve patient care
Read More
Nov 15, 2019
Industrial Production Processes (IPP) Ltd today announced that it has signed a contract with BBI Solutions Ltd to deliver a Ginolis Lateral Flow Device Assembly (LFDA) system.
Read More
Oct 18, 2019
30 Sept. 2019, UKCoronary heart disease is one of the leading causes of death within the UK. Every day over 2500 patients present at A&E departments across the UK with chest pain, indicative of a suspected heart attack. Of these, only 20% will have a confirmed heart attack. Diagnosis often takes several hours after arriving at A&E while healthcare professionals wait for test results to be processed by the hospital laboratory. Faster identification of these patients will save lives and im...
Read More
Sep 27, 2019
Special Projects Laboratory opened in EKF’s Cardiff HQ to develop new applications in non-core markets and support other global diagnostics R&D facilities
Read More
Sep 10, 2019
Studies confirm strong analytical performance for body fluid and pathological sample analysis of HELO platform
Read More
Jul 26, 2019
Specific, intermediate glycemic control marker for diabetes at EKF’s Booth #2952 at AACC 2019 Clinical Lab Expo – 6-8th August 2019
Read More
Jul 16, 2019
POC HbA1c study at Great Western Hospitals NHS Foundation Trust is finalist for 2019 RCOphth/Bausch+Lomb Sustainability Prize
Read More
Jun 17, 2019
Oxford, UK – 13 June 2019. Oxford Gene Technology (OGT), The Molecular Genetics Company, has expanded its SureSeq™ portfolio with a complete library preparation solution for hybridisation-based target capture in NGS, making its market-leading coverage uniformity and expertise even more accessible.
Read More
Page 2 of 11 [2]